Image

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Participate in MINI study to help improve newborn care data.

Recruiting
1 years and younger
All
Phase N/A

The goal of this study is to collect and track information about babies born very early, at 22-23 weeks of pregnancy, and admitted to intensive care. This information, called a "minimum dataset," helps doctors understand how these babies and their mothers are doing. The dataset includes details about the mother's health, the baby’s health, and any medical help the baby receives.

Data collection involves observing and recording basic information like the age and health of the mother and baby, as well as any medical treatments the baby gets. This information helps hospitals improve care, study how treatments affect baby outcomes, and observe health trends.

Eligibility for this study includes babies born locally or admitted to intensive care at 22-23 weeks of pregnancy. Hospitals can also choose to include babies born before 22 weeks if they want.

  • **No extra visits needed**: This is an observational study, so no additional hospital visits are required.
  • **No direct compensation**: Participation in this study does not offer any direct payment.
  • **No treatment provided**: This study only collects information, it does not offer any new treatments.
Study details
    Infant
    Extremely Premature
    Obstetric Labor
    Premature
    Premature Birth
    Intensive Care
    Neonatal
    Intensive Care Units
    Neonatal

NCT05685745

The University of Texas Health Science Center, Houston

18 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.